LobbyingMpharma Data lobbying by quarter
Mpharma Data's latest lobbying report covers Q2 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Mpharma Data
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$50K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Commerce, Dept of (DOC)2 reports
- Export-Import Bank of the United States (EXIM Bank)2 reports
- State, Dept of (DOS)2 reports
- U.S. Agency for International Development (USAID)2 reports
- White House Office2 reports
Firms it paid
| Firm | ||
|---|---|---|
| KRL International | $50K | 3 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/07/10for Q2 2023 | KRL International | Under $5,000 |
| 23/04/18for Q1 2023 | KRL International | $20K |
| 23/01/18for Q4 2022 | KRL International | $30K |